BB
WVE icon

BB Biotech’s Wave Life Sciences WVE Stock Holding History

BB Biotech’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$56.9M Hold
1,465,002
– – 1.43% 23
2018
Q4 		$61.6M Buy
1,465,002
+80,000
+6% +$3.56M 1.97% 17
2018
Q3 		$69.3M Buy
1,385,002
+247,117
+22% +$11.1M 1.83% 18
2018
Q2 		$43.5M Buy
1,137,885
+241,789
+27% +$10.4M 1.26% 21
2018
Q1 		$35.9M Buy
896,096
+40,000
+5% +$1.68M 0.99% 22
2017
Q4 		$30M Buy
+856,096
New +$25M 0.85% 21

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BB Biotech's WVE Position: Q1 2019 in Review

BB Biotech held its Wave Life Sciences (WVE) position steady in Q1 2019 at 1,465,002 shares worth $56.9M. The position accounts for 1.43% of the portfolio, ranked #23.

BB Biotech first reported a position in WVE in Q4 2017 and has held it in 6 quarters since. The position peaked at $69.3M in Q3 2018. 110 funds tracked by Wall St. Rank hold WVE as of Q1 2019.

  • BB Biotech held 1,465,002 shares of Wave Life Sciences worth $56.9M as of Q1 2019.
  • BB Biotech left its Wave Life Sciences share count unchanged in Q1 2019.
  • Wave Life Sciences made up 1.43% of BB Biotech's portfolio in Q1 2019, its #23 holding.
  • BB Biotech first reported a position in Wave Life Sciences in Q4 2017 and has held it in 6 quarters since.
  • BB Biotech's Wave Life Sciences position peaked at $69.3M in Q3 2018.
  • 110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2019.

Based on BB Biotech's 13F filing for Q1 2019, filed 13 May 2019.